Vivos Therapeutics, Inc. (VVOS)

USD 2.12

(1.68%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 10.73 Million 13.72 Million 33.68 Million 25.32 Million 7.55 Million 8.2 Million
Total Current Assets 2.46 Million 5.42 Million 27.32 Million 20.39 Million 1.98 Million 2.01 Million
Cash And Short Term Investments 1.64 Million 3.51 Million 24.03 Million 18.2 Million 469.35 Thousand 1.25 Million
Cash and Cash Equivalents 1.64 Million 3.51 Million 24.03 Million 18.2 Million 469.35 Thousand 1.25 Million
Short Term Investments - - - - - -
Net Receivables 202 Thousand 457 Thousand 1.71 Million 1.51 Million 955.98 Thousand 595.18 Thousand
Inventory 1.00 - - 1.00 263.81 Thousand 1.00
Other Current Assets 616 Thousand 1.44 Million 1.57 Million 673.06 Thousand 295 Thousand 27.75 Thousand
Total Non-Current Assets 8.26 Million 8.29 Million 6.36 Million 4.93 Million 5.56 Million 6.19 Million
Net PPE 4.69 Million 4.77 Million 2.82 Million 871.59 Thousand 1.13 Million 1.28 Million
Good Will And Intangible Assets 3.26 Million 3.14 Million 3.18 Million 2.94 Million 3.36 Million 4.88 Million
Good Will 2.84 Million 2.84 Million 2.84 Million 2.67 Million 2.67 Million 3.74 Million
Intangible Assets 420 Thousand 302 Thousand 341 Thousand 270.12 Thousand 689.15 Thousand 1.14 Million
Long-Term Investments - - - 810.63 Thousand 785.06 Thousand -
Tax Assets - - - -810.63 Thousand -785.06 Thousand -
Other Non Current Assets 307 Thousand 374 Thousand 356 Thousand 1.12 Million 1.06 Million 26.9 Thousand
Other Assets - - - - - -
Total Liabilities 10.31 Million 8.91 Million 8.15 Million 8.41 Million 10.49 Million 3.37 Million
Total Current Liabilities 7.28 Million 6.81 Million 7.5 Million 7.82 Million 9.09 Million 2.15 Million
Account Payables 2.14 Million 1.41 Million 920 Thousand 2.28 Million 1.08 Million 474.08 Thousand
Tax Payables - - - - - -
Short Term Debt 474 Thousand 419 Thousand 1.33 Million 866.97 Thousand 3.7 Million 161.54 Thousand
Deferred Revenue 2.13 Million 2.92 Million 2.39 Million 2.93 Million 2.94 Million 889.5 Thousand
Other Current Liabilities 2.53 Million 2.05 Million 2.85 Million 1.73 Million 1.35 Million 632.02 Thousand
Total Non Current Liabilities 3.03 Million 2.1 Million 641 Thousand 587.06 Thousand 1.4 Million 1.22 Million
Long-Term Debt 1.52 Million 1.99 Million 298 Thousand 423.09 Thousand - 525 Thousand
Deferred Revenue Non Current 289 Thousand 112 Thousand - - - -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 1.22 Million 112 Thousand 343 Thousand 163.96 Thousand 1.4 Million 695.01 Thousand
Other Liabilities - - - - - -
Total Equity 411 Thousand 4.8 Million 25.53 Million 16.91 Million -2.94 Million 4.82 Million
Stock Holders Equity 411 Thousand 4.8 Million 25.53 Million 16.91 Million -2.94 Million 4.82 Million
Common Stock - 2000.00 2000.00 1821.00 1244.00 1207.00
Retained Earnings -93.05 Million -79.46 Million -55.62 Million -35.33 Million -23.27 Million -12.52 Million
Accumulated other comprehensive income - - - -1.5 Million -1.31 Million -666.66 Thousand
Common Stock Equity 411 Thousand 4.8 Million 25.53 Million 16.91 Million -2.94 Million 4.82 Million
Capital Lease Obligation 1.52 Million 2.41 Million 367 Thousand - - -
Total Investments - - - 810.63 Thousand 785.06 Thousand -
Total Debt 1.99 Million 2.41 Million 1.63 Million 1.29 Million 3.7 Million 686.54 Thousand
Net Debt 352 Thousand -1.1 Million -22.39 Million -16.91 Million 3.24 Million -568.17 Thousand

Balance Sheet Charts

Created with Highcharts 11.1.0Value in USDYearly Balance Sheet BreakdownCurrent AssetsNon-Current AssetsCurrent LiabilitiesNon-Current LiabilitiesEquity2020202120222023010 M20 M30 M40 M
Created with Highcharts 11.1.0Current RatioWorking CapitalAnnual Working CapitalSource: YRWorking CapitalCurrrent Ratio202020212022202300.81.62.43.24-8 M08 M16 M24 M32 M